✦ LIBER ✦

Effectiveness and safety of a new protocol of intrapulmonary administration of urokinase in massive pulmonary embolism

✍ Scribed by S. Sala; R. Galeotti; M. Tilli; A. Giombi; P. Mannella

Publisher: Springer
Year: 2001
Tongue: English
Weight: 145 KB
Volume: 8
Category: Article
ISSN: 1070-3004
DOI: 10.1007/pl00011933

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical application of a new rheolytic

Clinical application of a new rheolytic thrombectomy catheter system for massive pulmonary embolism

✍ Thomas Voigtländer; Hans-Jürgen Rupprecht; Bernd Nowak; Felix Post; Eckhard Maye 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

Function and morphology of the myocardiu

Function and morphology of the myocardium in experimental massive pulmonary arterial embolism

✍ V. V. Karpova; M. S. Tverskaya; A. O. Virganskii; V. V. Banin; E. I. Tikhvinskay 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 691 KB

Rheolytic thrombectomy in patient with m

Rheolytic thrombectomy in patient with massive pulmonary embolism: A case report and review of literature

✍ Tejas Brahmbhatt; Sean Tutton; Patrick Mannebach; Michael Cinquegrani 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 1 views

Development of polyethylene glycol-conju

Development of polyethylene glycol-conjugated alendronate, a novel nitrogen-containing bisphosphonate derivative: Evaluation of absorption, safety, and effects after intrapulmonary administration in rats

✍ Hidemasa Katsumi; Miki Takashima; Jun-Ichi Sano; Kazushi Nishiyama; Noriko Kitam 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB

Bisphosphonates are widely used for the treatment of bone diseases, including hypercalcemia and osteoporosis. However, the bioavailability (BA) of orally administered bisphosphonates is low, at approximately 0.9%-1.8%. In addition, the oral administration of bisphosphonates is associated with mucosa

Successful treatment of massive pulmonar

Successful treatment of massive pulmonary embolism with recombinant tissue type plasminogen activator (rt-PA) in a pregnant woman with intact gravidity and preterm labour

✍ Th. Floßdorf; M. Breulmann; H. -B. Hopf 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 482 KB

Efficacy and Safety of a New 20% Immunog

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency

✍ John B. Hagan; Mary B. Fasano; Sheldon Spector; Richard L. Wasserman; Isaac Mela 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 197 KB